Reliable Data You Can Trust
Reliable Data You Can Trust
A recent
report published by Infinium Global Research on the travel vaccine market
provides an in-depth analysis of segments and sub-segments in the global as
well as regional travel vaccine market. The study also highlights the impact of
drivers, restraints, and macro indicators on the global and regional travel
vaccine market over the short term as well as the long term. The report is a
comprehensive presentation of trends, forecast and dollar values of the global
travel vaccine market. According to the report, the global travel vaccine
market is projected to grow at a CAGR of 9.2% over the forecast period of
2019-2025.
Market Insight
The number
of people traveling worldwide has increased substantially since the mode of
transport via air, land, and sea has developed considerably. People travel
abroad for business, holidays, studying, medical care, adventure, visiting
friends and relatives, etc. thereby carrying with their pathogens and vectors
resulting in pandemic diseases. Moreover, there are also concerns regarding
health issues arising from disease outbreaks or natural disasters to certain
international destinations thereby affecting travelers’ health. For e.g. an outbreak of yellow fever in Nigeria in September 2017. As a result, countries
established entry requirements on vaccination for travelers to protect from
spreading or importing the disease. Thus, one of the effective methods for travelers
to prevent disease is vaccination. Vaccination is a process of introducing a vaccine i.e. a biological preparation that stimulates the body’s immune system
to a particular disease. Travel vaccines also referred to as travel
immunizations are shots that have to be taken by travelers to help protect them
from infectious diseases before they visit particular areas of the world.
However, a travel vaccine should be taken 1 month before traveling.
According to the UN World Tourism
Organization, in 2018 international tourist arrival reached 1.4
billion. This enormous rise in the number of tourists is the major factor
enhancing the travel vaccine market. In addition to this, other factors such as
meeting travel expenses, expanding business models, and visa facilitation bring
about an exponential leap in traveling which in turn drives the travel vaccine
market. Furthermore, stringent regulations for health safety by regional
government bodies also fuelling the growth of the market. However, on the other
hand, high cost and unskillful resource persons for the production of disease-specific vaccines may hamper the market. Moreover, advancements in
technology, awareness programs by government and private organizations, and an
outbreak of diseases come up with greater opportunities for the growth of the
travel vaccine market during the forecast period.
On the basis
of region, the market is categorized into North America, Europe, Asia Pacific,
and RoW. North America is dominating the travel vaccine market due to good
reimbursement policies and a large number of key players in this region. The
European travel vaccine market expects to boost owing to raising awareness of
the diseases among the population as well as research on the development of
disease-specific vaccines. Asia Pacific market will surge during the forecast
period because of rising funds and an increase in the number of people
traveling abroad for studies, careers, medical care, etc.
Segment Covered
The report
on the global travel vaccine market covers segments such as composition type
and disease type. On the basis of composition, the sub-markets include mono
vaccine, and combination vaccines. On the basis of type, the sub-markets
include attenuated vaccines, inactive vaccines, subunit vaccines, toxoid
vaccines, conjugate vaccines, DNA vaccines, and recombinant vector vaccines. On
the basis of disease type, the sub-markets include hepatitis A, hepatitis B,
typhoid, and paratyphoid fever, meningococcal disease, yellow fever, rabies,
Japanese encephalitis, and others.
Companies Profiled:
The report
provides profiles of the companies in the market such as GlaxoSmithKline plc,
Pfizer Inc., F. Hoffman-La Roche Ltd., Merck & Co., Inc., Abbott
Laboratories, Sanofi S.A, Dynavax Technologies Corporation, Shenzhen Kangtay
Biological Products Co., Baxter International, Takeda Pharmaceuticals U.S.A.,
Inc., and other companies.
Report Highlights:
The report
provides deep insights into demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of the travel vaccine market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings insight into the market share of the leading players.
Please Choose One of them.